View up-to-date information on Momenta Pharmaceuticals Inc patents, including inventor and filing insights.
|Publication Identifier||Document Type||Title||Classification-CPC||Publication Date|
|US11352415B2||Grant||Methods for the treatment of neurodegeneration||A61K2039/505; A61K2039/54; A61K2039/545; C07K16/00; C07K16/06; C07K2317/41; G01N2333/52; G01N2500/10; G01N33/6896||June 07, 2022|
|US11345751B2||Grant||FcRn antibodies and methods of use thereof||A61P37/02; C07K16/28; C07K2317/565||May 31, 2022|
|WO2022109327A1||Application||SIALYLATED GLYCOPROTEINS||C07K9/001; G01N2400/00; G01N2458/15; G01N33/6848; G01N33/6857||May 27, 2022|
|US20220153833A1||Application||METHODS RELATED TO ENGINEERED Fc CONSTRUCTS||C07K16/283; C07K2317/35; C07K2317/52||May 19, 2022|
|IL291465D0||Application||Compositions and methods related to engineered fc-antigen binding domain constructs targeted to cd38||A61K2039/505; A61P35/02; C07K16/2896; C07K2317/52; C07K2317/64; C07K2317/72; C07K2317/732; C07K2317/734||May 01, 2022|
Top Inventors by Filings (Count by publication)
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer